Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

RICHARD JOHN LIZAK

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1972552370
CMS profile
180622
Location
LEHIGHTON, PA

General Payments · PY2018–2024

$1,326.20

  • Reported across 82 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$277.85

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $277.85 14

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $76.37 4
Lilly USA, LLC $56.27 3
Boehringer Ingelheim Pharmaceuticals, Inc. $45.32 2
PFIZER INC. $34.89 2
Exact Sciences Corporation $26.41 1
Radius Health, Inc. $19.39 1
Novo Nordisk AS $19.20 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $142.63 11
PY2019 $117.46 8
PY2020 $117.90 7
PY2021 $255.35 17
PY2022 $160.83 10
PY2023 $254.18 15
PY2024 $277.85 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $20.84 03/20/2024 Food and Beverage Undisputed 01/23/2026 1104391419 CMS
AstraZeneca Pharmaceuticals LP $13.31 08/21/2024 Food and Beverage Undisputed 01/23/2026 1105547219 CMS
AstraZeneca Pharmaceuticals LP $22.69 10/24/2024 Food and Beverage Undisputed 01/23/2026 1104489070 CMS
AstraZeneca Pharmaceuticals LP $19.53 11/07/2024 Food and Beverage Undisputed 01/23/2026 1105539013 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $22.15 01/24/2024 Food and Beverage Undisputed 01/23/2026 1118256926 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $23.17 08/07/2024 Food and Beverage Undisputed 01/23/2026 1118256928 CMS
Exact Sciences Corporation $26.41 05/01/2024 Food and Beverage Undisputed 01/23/2026 1114760285 CMS
Lilly USA, LLC $19.48 04/17/2024 Food and Beverage Undisputed 01/23/2026 1135386999 CMS
Lilly USA, LLC $23.58 09/04/2024 Food and Beverage Undisputed 01/23/2026 1135388767 CMS
Lilly USA, LLC $13.21 09/18/2024 Food and Beverage Undisputed 01/23/2026 1135388765 CMS
Novo Nordisk Inc $19.20 12/12/2024 Food and Beverage Undisputed 01/23/2026 1096834342 CMS
PFIZER INC. $17.71 03/06/2024 Food and Beverage Undisputed 01/23/2026 1131227708 CMS
PFIZER INC. $17.18 06/26/2024 Food and Beverage Undisputed 01/23/2026 1131740918 CMS
Radius Health, Inc. $19.39 07/17/2024 Food and Beverage Undisputed 01/23/2026 1089986840 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.